These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26215936)

  • 1. Is the Benign Breast Disease Breast Cancer Model Well Calibrated?
    Gail MH; Pfeiffer RM
    J Clin Oncol; 2015 Sep; 33(25):2829-30. PubMed ID: 26215936
    [No Abstract]   [Full Text] [Related]  

  • 2. Model for individualized prediction of breast cancer risk after a benign breast biopsy.
    Pankratz VS; Degnim AC; Frank RD; Frost MH; Visscher DW; Vierkant RA; Hieken TJ; Ghosh K; Tarabishy Y; Vachon CM; Radisky DC; Hartmann LC
    J Clin Oncol; 2015 Mar; 33(8):923-9. PubMed ID: 25624442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reply to M.H. Gail et al.
    Pankratz VS; Degnim AC; Vierkant RA; Frank RD; Hartmann LC
    J Clin Oncol; 2015 Sep; 33(25):2830-1. PubMed ID: 26215951
    [No Abstract]   [Full Text] [Related]  

  • 4. Integrating tools for breast cancer risk assessment, risk reduction, and early detection.
    Ward EM; Smith RA
    Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2428-9. PubMed ID: 20929880
    [No Abstract]   [Full Text] [Related]  

  • 5. Recent developments in the ability to predict and modify breast cancer risk.
    Prado A; Andrades P; Parada F
    J Plast Reconstr Aesthet Surg; 2010 Oct; 63(10):1581-7. PubMed ID: 19666246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer management, its triumphs and challenges.
    Begley MG
    Del Med J; 1999 Sep; 71(9):369-70. PubMed ID: 10584434
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast-tissue sampling for risk assessment and prevention.
    Fabian CJ; Kimler BF; Mayo MS; Khan SA
    Endocr Relat Cancer; 2005 Jun; 12(2):185-213. PubMed ID: 15947097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of isolated pathologic, thermographic, and physiologic abnormalities preceding breast cancer.
    Escobar PF; Keith L; Reeves W
    Int J Fertil Womens Med; 2005; 50(6):278-80. PubMed ID: 16526419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benign breast lesions at risk of developing cancer--a challenging problem in breast cancer screening programs: five years' experience of the Breast Cancer Screening Program in Verona (1999-2004).
    Manfrin E; Mariotto R; Remo A; Reghellin D; Falsirollo F; Dalfior D; Bricolo P; Piazzola E; Bonetti F
    Cancer; 2009 Feb; 115(3):499-507. PubMed ID: 19117040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New approaches to the imaging, diagnosis, and biopsy of breast lesions.
    Esserman LJ
    Cancer J; 2002; 8 Suppl 1():S1-14. PubMed ID: 12075695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. When and when not to biopsy the breast.
    Newstead G
    Diagn Imaging (San Franc); 1993 Mar; 15(3):111, 115-6. PubMed ID: 10148387
    [No Abstract]   [Full Text] [Related]  

  • 12. Ductal lavage for breast cancer risk assessment.
    Newman LA; Blake C
    Cancer Control; 2002; 9(6):473-9. PubMed ID: 12514565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TMEM: a novel breast cancer dissemination marker for the assessment of metastatic risk.
    Oktay MH; Jones JG
    Biomark Med; 2015; 9(2):81-4. PubMed ID: 25689896
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors associated with imaging and procedural events used to detect breast cancer after screening mammography.
    Carney PA; Abraham LA; Miglioretti DL; Yabroff KR; Sickles EA; Buist DS; Kasales CJ; Geller BM; Rosenberg RD; Dignan MB; Weaver DL; Kerlikowske K;
    AJR Am J Roentgenol; 2007 Feb; 188(2):385-92. PubMed ID: 17242246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical assessment of benign breast disease in screening.
    Monypenny IJ
    Br J Clin Pract Suppl; 1989 Nov; 68():118-20; discussion 133-6. PubMed ID: 2488553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up recommendations for benign breast biopsies.
    Shin S; Schneider HB; Cole FJ; Laronga C
    Breast J; 2006; 12(5):413-7. PubMed ID: 16958957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer in 2007: incidence, risk assessment, and risk reduction strategies.
    Lester J
    Clin J Oncol Nurs; 2007 Oct; 11(5):619-22. PubMed ID: 17962169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign breast disease--the risks of communicating risk.
    Elmore JG; Gigerenzer G
    N Engl J Med; 2005 Jul; 353(3):297-9. PubMed ID: 16034016
    [No Abstract]   [Full Text] [Related]  

  • 19. Controversies in benign breast disease.
    Marchant DJ
    Surg Oncol Clin N Am; 1998 Apr; 7(2):285-98. PubMed ID: 9537977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. It's Not All About Breast Density: Risk Matters.
    Dolan NC; Goel MS
    Ann Intern Med; 2015 May; 162(10):729-30. PubMed ID: 25984851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.